• Affiliate Associate Professor, Global Health

Seattle, WA
United States

Phone Number: 
Select from the following:

Dr. Brewer is trained and ACP Board Certified in Internal Medicine and Gastroenterology with a career in US Army R&D Command in anti parasitic, tropical disease drug and vaccine development and research training and 14 years endemic country experience. Dr. Brewer retired from Bill and Melinda Gates Foundation after 11 years (2013) as Strategy Program Lead Enteric Diseases. His interests include tropical enteric diseases, malnutrition, drug and vaccine safety and monitoring. Dr. Brewer has first-hand experience in non-clinical, clinical and post licensing drug/vaccine development, and is now primarily interested in teaching and mentoring opportunities for US and foreign students. See here for more information about Dr. Brewer's status and activities. 

  • MD (University of Mississippi)
  • BS (University of Southern Mississippi)
Country Affiliations 
Health Topics 
  • Diarrheal Diseases
  • Drug and Vaccine Development
  • Infectious Diseases
  • Pharmaceutical Science
DGH Centers, Programs and Initiatives and Affiliated Organizations 

Keusch GT, Denno DM, Black RE, Duggan C, Guerrant RL, Lavery JV, Nataro JP,
Rosenberg IH, Ryan ET, Tarr PI, Ward H, Bhutta ZA, Coovadia H, Lima A,
Ramakrishna B, Zaidi AK, Hay Burgess DC, Brewer T. Environmental enteric
dysfunction: pathogenesis, diagnosis, and clinical consequences. Clin Infect Dis.
2014 Nov 1;59 Suppl 4:S207-12.

Young GP, Mortimer EK, Gopalsamy GL, Alpers DH, Binder HJ, Manary MJ,
Ramakrishna BS, Brown IL, Brewer TG. Zinc deficiency in children with
environmental enteropathy-development of new strategies: report from an expert workshop. Am J Clin Nutr. 2014 Oct;100(4):1198-207.

Stewart VA, McGrath S, Krieg AM, Larson NS, Angov E, Smith CL, Brewer TG,
Heppner DG Jr. Activation of innate immunity in healthy Macaca mulatta macaques by a single subcutaneous dose of GMP CpG 7909: safety data and
interferon-inducible protein-10 kinetics for humans and macaques. Clin Vaccine
Immunol. 2008 Feb;15(2):221-6.

attabongkot J, Yimamnuaychoke N, Leelaudomlipi S, Rasameesoraj M, Jenwithisuk R, Coleman RE, Udomsangpetch R, Cui L, Brewer TG. Establishment of a human hepatocyte line that supports in vitro development of the eco-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax. Am J Trop Med Hyg. 2006 May;74(5):708-15.

Brewer TG, Genovese RF, Newman DB, Li Q. Factors relating to neurotoxicity of
artemisinin antimalarial drugs "listening to arteether". Med Trop (Mars).
1998;58(3 Suppl):22-7.